# A Study In Adults With Moderate To Severe Dermatomyositis

> **NCT03181893** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 75 (actual)

## Conditions studied

- Dermatomyositis

## Interventions

- **DRUG:** PF-06823859 low
- **DRUG:** Placebo Arm
- **DRUG:** PF-06823859 high

## Key facts

- **NCT ID:** NCT03181893
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-23
- **Primary completion:** 2022-05-27
- **Final completion:** 2022-11-28
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03181893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03181893, "A Study In Adults With Moderate To Severe Dermatomyositis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03181893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*